This is a preview of subscription content, log in to check access.
Dreyling M, et al. Long-term efficacy and safety from the copanlisib chronos-1 study in patients with relapsed or refractory indolent B-cell lymphoma. Blood 132 (Suppl. 1): 1595, Nov 2018. Available from: URL: http://doi.org/10.1182/blood-2018-99-114842 [abstract] - GermanyGoogle Scholar